Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000067

EVP, Chief Development Officer sold 4,141 shares at $75.66 ($313,308)

  • EVP, Chief Development Officer acquired 11,119 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kordasiewicz Holly B. · EVP, Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-15 Exercise or conversion : show line 1 in the form +11,119 18,859 D
2026-01-16 Sale : show line 2 in the form −4,141 $75.66 $313,308 14,718 D
Open-market sales · 4,141 sh · avg $75.66 · $313,308

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-01-15 Exercise or conversion : show line 3 in the form Restricted Stock Unit −11,119 20,830 D
2026-01-15 Grant or award : show line 4 in the form Restricted Stock Unit +13,650 34,480 D
2026-01-15 Grant or award : show line 5 in the form Restricted Stock Unit +11,250 45,730 D
Loading xslF345X05/edgardoc.xml…